Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Bedridden, Body temperature, COVID-19, Pyrexia, SARS-CoV-2 test
Clinical narrative: Patient tested positive for Covid-19 on 19JUN2022 after receiving her primary series of vaccine and her first booster dose of the Moderna Covid-19 vaccine.; stayed in bed for a day; higher temperature of 101 degrees Farenheight after her first Moderna Covid-19 booster dose; This spontaneous case was reported by a patient and describes the occurrence of BEDRIDDEN (stayed in bed for a day), PYREXIA (higher temperature of 101 degrees Farenheight after her first Moderna Covid-19 booster dose) and COVID-19 (Patient tested positive for Covid-19 on 19JUN2022 after receiving her primary series of vaccine and her first booster dose of the Moderna Covid-19 vaccine.) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 067F21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 20-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Nov-2021, the patient experienced BEDRIDDEN (stayed in bed for a day) and PYREXIA (higher temperature of 101 degrees Farenheight after her first Moderna Covid-19 booster dose). On 19-Jun-2022, the patient experienced COVID-19 (Patient tested positive for Covid-19 on 19JUN2022 after receiving her primary series of vaccine and her first booster dose of the Moderna Covid-19 vaccine.). On 20-Nov-2021, BEDRIDDEN (stayed in bed for a day) had resolved. At the time of the report, PYREXIA (higher temperature of 101 degrees Farenheight after her first Moderna Covid-19 booster dose) and COVID-19 (Patient tested positive for Covid-19 on 19JUN2022 after receiving her primary series of vaccine and her first booster dose of the Moderna Covid-19 vaccine.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Nov-2021, Body temperature: 101 higher temperature of 101 degrees Farenheight. On 19-Jun-2022, SARS-CoV-2 test: (Positive) Positive.         No concomitant information was reported. No treatment information was reported.  Company Comment: This is a spontaneous case concerning a 67-year-old female patient with no reported medical history, who experienced the unexpected, non-serious adverse event of special interest of COVID-19 (with SARS-CoV-2 test positive), approximately 7 months after receiving the third dose of mRNA-1273 vaccine. Clinical course and treatment details were not provided in the case. The outcome of the event was unknown at the time of the report. The benefit-risk relationship of mRNA-1273 is not affected by this report.   This case was linked to MOD-2022-609295 (Patient Link).; Sender's Comments: This is a spontaneous case concerning a 67-year-old female patient with no reported medical history, who experienced the unexpected, non-serious adverse event of special interest of COVID-19 (with SARS-CoV-2 test positive), approximately 7 months after receiving the third dose of mRNA-1273 vaccine. Clinical course and treatment details were not provided in the case. The outcome of the event was unknown at the time of the report. The benefit-risk relationship of mRNA-1273 is not affected by this report.